- Live Verdure (LV1) begins the week in a trading halt regarding a capital raising, acquisition and CEO appointment
- The food, skincare and nutraceutical company will remain in the halt until Wednesday, August 24, or when further details are released to the market, whichever occurs first
- Prior to entering the trading halt, Live Verdure’s most recent news was the release of its June quarterly where in tabled unaudited sales of $503,000
- As of June 30, Live Verdure had $538,000 in total available funding, representing less than one quarter of funding, suggesting it will benefit from a capital raise
- Shares in Live Verdure last traded at 15 cents on August 11
Live Verdure (LV1) has begun the week in a trading halt regarding a capital raising, acquisition and CEO appointment.
The food, skincare and nutraceutical company will remain in the halt until Wednesday, August 24, or when further details are released to the market, whichever occurs first.
Live Verdure is yet to disclose any information regarding how much it intends to raise and what it will use the money for, what it will be acquiring or who the CEO will be.
Prior to entering the trading halt, Live Verdure’s most recent news was the release of its June quarterly report.
The period was highlighted by the company tabling unaudited sales of $503,000 for the three months ending June 30, representing a 182 per cent increase from the prior corresponding period.
Of this, online sales totalled $499,000, making up 99 per cent of Live Verdure’s total sales.
Live Verdure achieved a record revenue of $1.91 million for FY22, representing a 215 per cent increase from FY21.
Live Verdure burnt through $820,000 in the quarter with the majority going towards advertising and marketing.
As of June 30, Live Verdure had $538,000 in total available funding, representing less than one quarter of funding, suggesting it will benefit from a capital raise.
Shares in Live Verdure last traded at 15 cents on August 11. The company has an $8.31 million market cap.